<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
  <channel>
    <ttl>30</ttl>
    <title>IMERonline.com - Anemia</title>
    <itunes:category xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" text="Education">
      <itunes:category text="Science"/>
    </itunes:category>
    <itunes:category xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" text="Science"/>
    <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"></itunes:subtitle>
    <link>http://www.imeronline.com</link>
    <language>en-us</language>
    <copyright>Institute for Medical Education and Research</copyright>
    <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
    <itunes:owner xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <itunes:name>Institute for Medical Education and Research</itunes:name>
      <itunes:email>podcast@imeronline.com</itunes:email>
    </itunes:owner>
    <description></description>
    <webMaster>podcast@imeronline.com</webMaster>
    <image>http://www.imeronline.com/podcast/itunes300x300.jpg</image>
    <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"></itunes:summary>
    <itunes:image xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" href="http://www.imeronline.com/podcast/itunes300x300.jpg"/>
    <itunes:explicit xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">clean</itunes:explicit>
    <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing</itunes:keywords>
    <item>
      <title>Cancer-Related Anemia: An Expert Panel Discussion</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 7</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/219_podcast_ep_7.mp4" length="12046737" type="video/mp4"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:08:22</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/219_podcast_ep_7.mp4</guid>
      <pubDate>Mon, 03 Dec 2007 12:07:57 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 12:07:57 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Advanced practice oncology nurses will participate in discussions of challenging cases in cancer-related anemia. Audience members will have the opportunity to test their understanding of how to treat complicated cases during an interactive question-and-answer presentation using Audience Response System (ARS) keypad technology.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, cancer-related anemia</itunes:keywords>
    </item>
    <item>
      <title>Survivor: Supportive Care</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 1</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/205_intro.mp4" length="6664926" type="video/mp4"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:05:54</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/205_intro.mp4</guid>
      <pubDate>Mon, 03 Dec 2007 12:22:10 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 12:22:10 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Management of cancer treatment side effects is among the key roles of nurses caring for cancer patients. CINV, CIA, and OM are among the most common and distressing toxicities of cancer treatment. They negatively impact patients’ quality of life and may cause treatment delays and interfere with patients’ outcomes. In this interactive game show symposium, a panel of thoughtleaders in oncology supportive care, who are cancer survivors themselves, will discuss key aspects of CINV, CIA, and OM management. Appropriate patient education will be highlighted.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, CINV, CIA, OM, toxicity, chemotherapy</itunes:keywords>
    </item>
    <item>
      <title>Survivor: Supportive Care</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 2</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/205_podcast_ep_1.mp4" length="38596573" type="video/mp4"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:29:41</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/205_podcast_ep_1.mp4</guid>
      <pubDate>Mon, 03 Dec 2007 12:23:16 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 12:23:16 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Management of cancer treatment side effects is among the key roles of nurses caring for cancer patients. CINV, CIA, and OM are among the most common and distressing toxicities of cancer treatment. They negatively impact patients’ quality of life and may cause treatment delays and interfere with patients’ outcomes. In this interactive game show symposium, a panel of thoughtleaders in oncology supportive care, who are cancer survivors themselves, will discuss key aspects of CINV, CIA, and OM management. Appropriate patient education will be highlighted.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, CINV, CIA, OM, toxicity, chemotherapy</itunes:keywords>
    </item>
    <item>
      <title>Survivor: Supportive Care</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 3</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/205_podcast_ep_2.mp4" length="28404789" type="video/mp4"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:21:41</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/205_podcast_ep_2.mp4</guid>
      <pubDate>Mon, 03 Dec 2007 12:25:28 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 12:25:28 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Management of cancer treatment side effects is among the key roles of nurses caring for cancer patients. CINV, CIA, and OM are among the most common and distressing toxicities of cancer treatment. They negatively impact patients’ quality of life and may cause treatment delays and interfere with patients’ outcomes. In this interactive game show symposium, a panel of thoughtleaders in oncology supportive care, who are cancer survivors themselves, will discuss key aspects of CINV, CIA, and OM management. Appropriate patient education will be highlighted.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, CINV, CIA, OM, toxicity, chemotherapy</itunes:keywords>
    </item>
    <item>
      <title>Survivor: Supportive Care</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 4</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/205_podcast_ep_3.mp4" length="59874515" type="video/mp4"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:45:34</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/205_podcast_ep_3.mp4</guid>
      <pubDate>Mon, 03 Dec 2007 12:27:17 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 12:27:17 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Management of cancer treatment side effects is among the key roles of nurses caring for cancer patients. CINV, CIA, and OM are among the most common and distressing toxicities of cancer treatment. They negatively impact patients’ quality of life and may cause treatment delays and interfere with patients’ outcomes. In this interactive game show symposium, a panel of thoughtleaders in oncology supportive care, who are cancer survivors themselves, will discuss key aspects of CINV, CIA, and OM management. Appropriate patient education will be highlighted.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, CINV, CIA, OM, toxicity, chemotherapy</itunes:keywords>
    </item>
    <item>
      <title>Controversies in Anemia Management</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 1</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/244_intro.m4v" length="82989815" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:08:43</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/244_intro.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 10:22:04 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 10:22:04 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">How well does the oncology nursing audience understand the latest issues and controversies in anemia management? Nationally recognized thought leaders will review the most pressing topics as they relate to CRA, including flexible dosing schedules of erythropoietic agents, appropriate use of concomitant iron, prevention and management of anemia in patients undergoing surgery followed by chemotherapy, and anemia prevention and management in patients with hematologic malignancies. This presentation will include a continuing education game show program titled Deal or No Deal, which will test participants’ understanding of CRA. This latest craze in game shows has never been played in such a setting before, so participants are in for a one-of-a-kind type of learning experience. The winning team will have the opportunity to donate $1,000 to its cancer-related charity of choice.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, anemia, CRA, anemia management</itunes:keywords>
    </item>
    <item>
      <title>Controversies in Anemia Management</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 2</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/244_stricker1.m4v" length="89009565" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:24:11</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/244_stricker1.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 10:23:16 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 10:23:16 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">How well does the oncology nursing audience understand the latest issues and controversies in anemia management? Nationally recognized thought leaders will review the most pressing topics as they relate to CRA, including flexible dosing schedules of erythropoietic agents, appropriate use of concomitant iron, prevention and management of anemia in patients undergoing surgery followed by chemotherapy, and anemia prevention and management in patients with hematologic malignancies. This presentation will include a continuing education game show program titled Deal or No Deal, which will test participants’ understanding of CRA. This latest craze in game shows has never been played in such a setting before, so participants are in for a one-of-a-kind type of learning experience. The winning team will have the opportunity to donate $1,000 to its cancer-related charity of choice.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, anemia, CRA, anemia management</itunes:keywords>
    </item>
    <item>
      <title>Controversies in Anemia Management</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 3</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/244_stricker2.m4v" length="24889433" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:06:16</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/244_stricker2.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 10:26:30 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 10:26:30 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">How well does the oncology nursing audience understand the latest issues and controversies in anemia management? Nationally recognized thought leaders will review the most pressing topics as they relate to CRA, including flexible dosing schedules of erythropoietic agents, appropriate use of concomitant iron, prevention and management of anemia in patients undergoing surgery followed by chemotherapy, and anemia prevention and management in patients with hematologic malignancies. This presentation will include a continuing education game show program titled Deal or No Deal, which will test participants’ understanding of CRA. This latest craze in game shows has never been played in such a setting before, so participants are in for a one-of-a-kind type of learning experience. The winning team will have the opportunity to donate $1,000 to its cancer-related charity of choice.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, anemia, CRA, anemia management</itunes:keywords>
    </item>
    <item>
      <title>Controversies in Anemia Management</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 4</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/244_nail.m4v" length="82049932" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:18:48</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/244_nail.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 10:31:28 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 10:31:28 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">How well does the oncology nursing audience understand the latest issues and controversies in anemia management? Nationally recognized thought leaders will review the most pressing topics as they relate to CRA, including flexible dosing schedules of erythropoietic agents, appropriate use of concomitant iron, prevention and management of anemia in patients undergoing surgery followed by chemotherapy, and anemia prevention and management in patients with hematologic malignancies. This presentation will include a continuing education game show program titled Deal or No Deal, which will test participants’ understanding of CRA. This latest craze in game shows has never been played in such a setting before, so participants are in for a one-of-a-kind type of learning experience. The winning team will have the opportunity to donate $1,000 to its cancer-related charity of choice.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, anemia, CRA, anemia management</itunes:keywords>
    </item>
    <item>
      <title>Controversies in Anemia Management</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 5</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/244_stanley1.m4v" length="71924452" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:18:02</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/244_stanley1.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 10:34:26 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 10:34:26 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">How well does the oncology nursing audience understand the latest issues and controversies in anemia management? Nationally recognized thought leaders will review the most pressing topics as they relate to CRA, including flexible dosing schedules of erythropoietic agents, appropriate use of concomitant iron, prevention and management of anemia in patients undergoing surgery followed by chemotherapy, and anemia prevention and management in patients with hematologic malignancies. This presentation will include a continuing education game show program titled Deal or No Deal, which will test participants’ understanding of CRA. This latest craze in game shows has never been played in such a setting before, so participants are in for a one-of-a-kind type of learning experience. The winning team will have the opportunity to donate $1,000 to its cancer-related charity of choice.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, anemia, CRA, anemia management</itunes:keywords>
    </item>
    <item>
      <title>Controversies in Anemia Management</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 6</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/244_stanley2.m4v" length="40755183" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:09:28</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/244_stanley2.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 10:49:19 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 10:49:19 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">How well does the oncology nursing audience understand the latest issues and controversies in anemia management? Nationally recognized thought leaders will review the most pressing topics as they relate to CRA, including flexible dosing schedules of erythropoietic agents, appropriate use of concomitant iron, prevention and management of anemia in patients undergoing surgery followed by chemotherapy, and anemia prevention and management in patients with hematologic malignancies. This presentation will include a continuing education game show program titled Deal or No Deal, which will test participants’ understanding of CRA. This latest craze in game shows has never been played in such a setting before, so participants are in for a one-of-a-kind type of learning experience. The winning team will have the opportunity to donate $1,000 to its cancer-related charity of choice.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, anemia, CRA, anemia management</itunes:keywords>
    </item>
    <item>
      <title>Controversies in Anemia Management</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 7</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/244_qa.m4v" length="63267721" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:16:27</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/244_qa.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 11:01:27 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 11:01:27 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">How well does the oncology nursing audience understand the latest issues and controversies in anemia management? Nationally recognized thought leaders will review the most pressing topics as they relate to CRA, including flexible dosing schedules of erythropoietic agents, appropriate use of concomitant iron, prevention and management of anemia in patients undergoing surgery followed by chemotherapy, and anemia prevention and management in patients with hematologic malignancies. This presentation will include a continuing education game show program titled Deal or No Deal, which will test participants’ understanding of CRA. This latest craze in game shows has never been played in such a setting before, so participants are in for a one-of-a-kind type of learning experience. The winning team will have the opportunity to donate $1,000 to its cancer-related charity of choice.&#13;
NOTE: This is the Q</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, anemia, CRA, anemia management</itunes:keywords>
    </item>
    <item>
      <title>Cancer-Related Anemia: An Expert Panel Discussion</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 1</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/219_1.m4v" length="162520432" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:05:19</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/219_1.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 11:54:14 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 11:54:14 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Advanced practice oncology nurses will participate in discussions of challenging cases in cancer-related anemia. Audience members will have the opportunity to test their understanding of how to treat complicated cases during an interactive question-and-answer presentation using Audience Response System (ARS) keypad technology.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, cancer-related anemia</itunes:keywords>
    </item>
    <item>
      <title>Cancer-Related Anemia: An Expert Panel Discussion</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 2</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/219_2.m4v" length="111064698" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:35:34</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/219_2.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 11:57:42 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 11:57:42 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Advanced practice oncology nurses will participate in discussions of challenging cases in cancer-related anemia. Audience members will have the opportunity to test their understanding of how to treat complicated cases during an interactive question-and-answer presentation using Audience Response System (ARS) keypad technology.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, cancer-related anemia</itunes:keywords>
    </item>
    <item>
      <title>Cancer-Related Anemia: An Expert Panel Discussion</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 3</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/219_3.m4v" length="33292775" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:11:04</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/219_3.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 11:58:35 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 11:58:35 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Advanced practice oncology nurses will participate in discussions of challenging cases in cancer-related anemia. Audience members will have the opportunity to test their understanding of how to treat complicated cases during an interactive question-and-answer presentation using Audience Response System (ARS) keypad technology.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, cancer-related anemia</itunes:keywords>
    </item>
    <item>
      <title>Cancer-Related Anemia: An Expert Panel Discussion</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 4</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/219_4.m4v" length="16283773" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:05:04</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/219_4.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 12:01:22 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 12:01:22 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Advanced practice oncology nurses will participate in discussions of challenging cases in cancer-related anemia. Audience members will have the opportunity to test their understanding of how to treat complicated cases during an interactive question-and-answer presentation using Audience Response System (ARS) keypad technology.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, cancer-related anemia</itunes:keywords>
    </item>
    <item>
      <title>Cancer-Related Anemia: An Expert Panel Discussion</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 5</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/219_5.m4v" length="38278130" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:13:10</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/219_5.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 12:02:32 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 12:02:32 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Advanced practice oncology nurses will participate in discussions of challenging cases in cancer-related anemia. Audience members will have the opportunity to test their understanding of how to treat complicated cases during an interactive question-and-answer presentation using Audience Response System (ARS) keypad technology.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, cancer-related anemia</itunes:keywords>
    </item>
    <item>
      <title>Cancer-Related Anemia: An Expert Panel Discussion</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 6</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/219_6.m4v" length="35132932" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:11:21</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/219_6.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 12:06:46 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 12:10:04 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Advanced practice oncology nurses will participate in discussions of challenging cases in cancer-related anemia. Audience members will have the opportunity to test their understanding of how to treat complicated cases during an interactive question-and-answer presentation using Audience Response System (ARS) keypad technology.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, cancer-related anemia</itunes:keywords>
    </item>
    <item>
      <title>Cancer-Related Anemia: An Expert Panel Discussion</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 8</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/219_8.m4v" length="32188092" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:10:18</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/219_8.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 12:11:16 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 12:11:16 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Advanced practice oncology nurses will participate in discussions of challenging cases in cancer-related anemia. Audience members will have the opportunity to test their understanding of how to treat complicated cases during an interactive question-and-answer presentation using Audience Response System (ARS) keypad technology.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, cancer-related anemia</itunes:keywords>
    </item>
    <item>
      <title>Cancer-Related Anemia: An Expert Panel Discussion</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 9</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/219_9.m4v" length="139703546" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:13:14</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/219_9.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 12:12:27 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 12:12:27 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Advanced practice oncology nurses will participate in discussions of challenging cases in cancer-related anemia. Audience members will have the opportunity to test their understanding of how to treat complicated cases during an interactive question-and-answer presentation using Audience Response System (ARS) keypad technology.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, cancer-related anemia</itunes:keywords>
    </item>
    <item>
      <title>Oncology Highlights 2005 Updated Clinical Research on Erythropoietic Agents for Chemotherapy-Induced Anemia</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 1</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/119_av_episode1.m4v" length="14810958" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:13:14</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/119_av_episode1.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 12:55:51 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 12:55:51 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Anemia, a well-known complication of cancer treatment, negatively impacts patients' quality of life. The introduction of erythropoietic agents has been a major advancement in the management of chemotherapy-induced anemia, and guidelines regarding the use of these agents have been developed. In this case-based symposium, updated clinical data on this topic will be presented. A discussion on the appropriate use of erythropoietic agents will help oncology nurses better understand the optimal use of these agents in clinical practice.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, anemia, quality of life, chemotherapy-induced, erythropoietic agents</itunes:keywords>
    </item>
    <item>
      <title>Oncology Highlights 2005 Updated Clinical Research on Erythropoietic Agents for Chemotherapy-Induced Anemia</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 2</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/119_av_episode2.m4v" length="37744657" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:32:43</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/119_av_episode2.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 14:21:17 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 14:21:17 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Anemia, a well-known complication of cancer treatment, negatively impacts patients' quality of life. The introduction of erythropoietic agents has been a major advancement in the management of chemotherapy-induced anemia, and guidelines regarding the use of these agents have been developed. In this case-based symposium, updated clinical data on this topic will be presented. A discussion on the appropriate use of erythropoietic agents will help oncology nurses better understand the optimal use of these agents in clinical practice.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, anemia, quality of life, chemotherapy-induced, erythropoietic agents</itunes:keywords>
    </item>
    <item>
      <title>Oncology Highlights 2005 Updated Clinical Research on Erythropoietic Agents for Chemotherapy-Induced Anemia</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 3</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/119_av_episode3.m4v" length="45180363" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:37:53</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/119_av_episode3.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 14:30:22 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 14:30:22 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Anemia, a well-known complication of cancer treatment, negatively impacts patients' quality of life. The introduction of erythropoietic agents has been a major advancement in the management of chemotherapy-induced anemia, and guidelines regarding the use of these agents have been developed. In this case-based symposium, updated clinical data on this topic will be presented. A discussion on the appropriate use of erythropoietic agents will help oncology nurses better understand the optimal use of these agents in clinical practice.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, anemia, quality of life, chemotherapy-induced, erythropoietic agents</itunes:keywords>
    </item>
    <item>
      <title>Oncology Highlights 2005 Updated Clinical Research on Erythropoietic Agents for Chemotherapy-Induced Anemia</title>
      <itunes:subtitle xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Episode 4</itunes:subtitle>
      <itunes:author xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Institute for Medical Education and Research</itunes:author>
      <enclosure url="http://www.imeronline.com/podcast/media/119_av_episode4.m4v" length="5687403" type="video/x-m4v"/>
      <itunes:duration xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">00:04:54</itunes:duration>
      <guid>http://www.imeronline.com/podcast/media/119_av_episode4.m4v</guid>
      <pubDate>Mon, 03 Dec 2007 14:31:28 -0500</pubDate>
      <lastBuildDate>Mon, 03 Dec 2007 14:31:28 -0500</lastBuildDate>
      <itunes:summary xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">Anemia, a well-known complication of cancer treatment, negatively impacts patients' quality of life. The introduction of erythropoietic agents has been a major advancement in the management of chemotherapy-induced anemia, and guidelines regarding the use of these agents have been developed. In this case-based symposium, updated clinical data on this topic will be presented. A discussion on the appropriate use of erythropoietic agents will help oncology nurses better understand the optimal use of these agents in clinical practice.</itunes:summary>
      <itunes:keywords xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">IMER Medical Education Oncology Nursing Cancer Oncology, anemia, quality of life, chemotherapy-induced, erythropoietic agents</itunes:keywords>
    </item>
  </channel>
</rss>
